The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Quantitative evaluation of oncogenic KRAS signaling and therapeutic effects of molecular-targeted drugs in living cells by single-molecule imaging.
 
Ryoma Yokoi
No Relationships to Disclose
 
Jesse Yu Tajima
No Relationships to Disclose
 
Shigeru Kiyama
No Relationships to Disclose
 
Yoshihiro Tanaka
No Relationships to Disclose
 
Katsutoshi Murase
No Relationships to Disclose
 
Manabu Futamura
No Relationships to Disclose
 
Kenichi Suzuki
No Relationships to Disclose
 
Nobuhisa Matsuhashi
Honoraria - Amco; Asahi Kasei; Chugai Pharma; Covidien; Daiichi Sankyo; Gunze Medical; Johnson & Johnson; Kaken Pharmaceutical; Lilly Japan; Merck KGaA; Miyarisan pharmaceutical; MSD; Ono Pharmaceutical; Stryker; Taiho Pharmaceutical; Takeda; TERUMO; Tsumura & Co.; Viatris; Yakult Honsha
Research Funding - Abbott (Inst); Asahi Kasei (Inst); Chugai Pharma (Inst); Covidien (Inst); Daiichi Sankyo (Inst); Eisai (Inst); EPS Corporation (Inst); EPS Holdings (Inst); Johnson & Johnson (Inst); Kaken Pharmaceutical (Inst); Kyowa Kirin (Inst); Lilly Japan (Inst); MSD K.K (Inst); Nippon Kayaku (Inst); Ono Pharmaceutical (Inst); Otsuka (Inst); Shift Zero (Inst); Taiho Pharmaceutical (Inst); TERUMO (Inst); Tsumura & Co. (Inst)